Anti-SCN2A Antibody, clone 3F19 ZooMAb® Rabbit Monoclonal

Кат. номер

ZRB1300-25UL

ZRB1300-4X25UL

ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.
Specificity
Clone 3F19 is a ZooMAb® Rabbit recombinant monoclonal antibody that specifically detects Sodium channel protein type 2 subunit alpha (SCN2A). It targets an epitope within 23 amino acids from the C-terminal, cytoplasmic domain.
KLH-conjugated linear peptide corresponding to 23 amino acids from the C-terminal, cytoplasmic domain of human Sodium channel protein type 2 subunit alpha (SCN2A).
Quality Control Testing
Evaluated by Western Blotting in Human brain tissue lysate.
Western Blotting Analysis: A 1:1,000 dilution of this antibody detected SCN2A in Human brain tissue lysate.
Tested applications
Western Blotting Analysis: A 1:1,000 dilution of this antibody detected SCN2A in Human hippocampus membrane preparations.
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected SCN2A in K562 cells (not permeabilized).
Affinity Binding Assay: A representative lot of this antibody bound SCN2A in SCN2A Sodium Channel with a KD of 1.2 x 10-8 in an affinity binding assay.
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-SCN2A, clone 3F19 ZooMAb®, Cat. No. ZRB1300, is a recombinant Rabbit monoclonal antibody that detects SCN2A and is tested for use in Affinity Binding Assay, Immunocytochemistry, and Western Blotting.
Target description
Sodium channel protein type 2 subunit alpha (UniProt: Q99250; also known as HBSC II, Sodium channel protein brain II subunit alpha, Sodium channel protein type II subunit alpha, Voltage-gated sodium channel subunit alpha Nav1.2, SCN2A) is encoded by the SCN2A (also known as NAC2, SCN2A1, SCN2A2) gene (Gene ID: 6326) in human. Sodium channels are integral plasma membrane proteins that conduct Na+ transport across the plasma membrane. They are classified as either voltage-gated or ligand-gated based on the nature of the triggering mechanism for channel activation. SCN2A is a multi-pass membrane glycoprotein with 13 cytoplasmic domains, 16 extracellular domains, and 24 transmembrane domains, and It mediates the voltage-dependent sodium ion permeability of excitable membranes. It forms a sodium-selective channel through which Na+ ions may pass in accordance with their electrochemical gradient. Mutations in SCN2A gene are known to cause infantile epileptic encephalopathy that is characterized by infantile-onset seizures, before 12 months of age, followed by neurodevelopmental delay. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Sanders, SJ., et al. (2018). Trends Neurosci. 41(7); 442-456).
Physical form
Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb® formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.
Reconstitution
300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Storage and Stability
Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Quality Level	200
biological source	rabbit
recombinant	expressed in HEK 293 cells
antibody form	purified antibody
antibody product type	primary antibodies
clone	3F19, recombinant monoclonal
description	recombinant, expressed in HEK 293 cells
product line	ZooMAb®
form	lyophilized
mol wt	calculated mol wt 227.98 kDa","observed mol wt ~260 kDa
purified by	using Protein A
species reactivity	human
species reactivity (predicted by homology)	monkey
packaging	antibody small pack of 25 µL
enhanced validation	recombinant expression
application(s)	affinity binding assay: suitable","immunocytochemistry: suitable","western blot: suitable
isotype	IgG
epitope sequence	C-terminal
conjugate	unconjugated
Protein ID accession no.	NP_001035232,
UniProt accession no.	Q99250,
shipped in	ambient
storage temp.	2-8°C